Advertisement
Advertisement
GENB
Generate Biomedicines, Inc. Common Stock
14.39
USDSponsored
-0.49
-3.41%
Jul 22, 15:59 UTC -4
Closed
Pre-Market
14.12
-0.28
-1.91%
GENB Earnings Reports
Positive Surprise Ratio
GENB beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Generate Biomedicines, Inc. Common Stock earnings per share and revenue
On May 07, 2026, GENB reported earnings of -1.06 USD per share (EPS) for Q1 26, missing the estimate of -0.51 USD, resulting in a -107.84% surprise. Revenue reached 7.22 million, compared to an expected 6.06 million, with a 19.28% difference. The market reacted with a -11.21% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AGNC Investment Corp. Depositary Shares
Report Date
Jul 20, 2026 For Q2 26
Estimate
$0.38
Actual
$0.40
Surprise
+2.88%
WesBanco, Inc. Depositary Shares
Report Date
Jul 21, 2026 For Q2 26
Estimate
$0.87
Actual
$0.92
Surprise
+5.67%
Hancock Whitney Corporation 6.25% Subordinated Notes due 2060
Report Date
Jul 21, 2026 For Q2 26
Estimate
$1.56
Actual
$1.55
Surprise
-0.99%
AGNC Investment Corp. Depositary Shares
Report Date
Jul 20, 2026 For Q2 26
Estimate
$0.38
Actual
$0.40
Surprise
+2.88%
Fulton Financial Corporation Depositary Shares
Report Date
Jul 22, 2026 For Q2 26
Estimate
$0.48
Actual
$0.60
Surprise
+24.77%
Old National Bancorp Depositary Shares
Report Date
Jul 22, 2026 For Q2 26
Estimate
$0.63
Actual
$0.65
Surprise
+2.19%
Alphabet Inc. Depositary Shares
Report Date
Jul 22, 2026 For Q2 26
Estimate
$2.97
Actual
$9.11
Surprise
+206.19%
Alphabet Inc. Depositary Shares
Report Date
Jul 22, 2026 For Q2 26
Estimate
$2.97
Actual
$9.11
Surprise
+206.19%
Bridgewater Bancshares, Inc. Depositary Shares
Report Date
Jul 21, 2026 For Q2 26
Estimate
$0.45
Actual
$0.45
Surprise
-1.60%
First Merchants Corporation Depository Shares
Report Date
Jul 22, 2026 For Q2 26
Estimate
$1.05
Actual
$0.74
Surprise
-29.60%
FAQ
What were Generate Biomedicines, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Generate Biomedicines, Inc. Common Stock reported EPS of -$1.06, missing estimates by -107.84%, and revenue of $7.22M, 19.28% above expectations.
How did the market react to Generate Biomedicines, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -11.21%, changed from $15.30 before the earnings release to $13.59 the day after.
When is Generate Biomedicines, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Generate Biomedicines, Inc. Common Stock's next earnings report?
Based on --
analysts, Generate Biomedicines, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement